Flamel Technologies SA (FLML) Soars: Stock Up 6.6%
moreView todays social media effects on IPCIView the latest stocks trending across Twitter. Click to view dashboardSee who Intellipharmaceutics is hiring next, click here to view […]
IPCI
Jennings Capital Initiates Coverage on Intellipharmaceutics Intl (NASDAQ:IPCI) (TSX:I) with a Speculative Buy Recommendation – Video Research Alert on InvestmentPitch.com
[Thomson Reuters ONE] – Vancouver, BC, March 14, 2014 – Investment firm Mackie Research has initiated coverage on Intellipharmaceutics International, (NASDAQ:IPCI) (TSX:I). Analyst Andre Uddin gives the company a speculative … moreView todays social media effects on IPCIView the latest stocks trending across Twitter. Click to view dashboardSee who Intellipharmaceutics is hiring next, click here to view […]
INTELLIPHARMACEUTICS INTERNATIONAL INC. Financials
moreView todays social media effects on IPCIView the latest stocks trending across Twitter. Click to view dashboardSee who Intellipharmaceutics is hiring next, click here to view […]
Intellipharmaceutics Announces 2013 Year End Results
[GlobeNewswire] – TORONTO — Intellipharmaceutics International Inc. , a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral … moreView todays social media effects on IPCIView the latest stocks trending across Twitter. Click to view dashboardSee who Intellipharmaceutics is hiring next, click here to view […]
Intellipharmaceutics Announces First Quarter 2013 Results
[at noodls] – TORONTO, April 3, 2013 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and … moreView todays social media effects on IPCIView the latest stocks trending across Twitter. Click to view dashboardSee who Intellipharmaceutics is hiring next, click here to view […]
Intellipharmaceutics Closes US$3.1 Million Registered Direct Offering of Units
[at noodls] – TORONTO, March 25, 2013 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and … moreView todays social media effects on IPCIView the latest stocks trending across Twitter. Click to view dashboardSee who Intellipharmaceutics is hiring next, click here to view […]
Intellipharmaceutics Announces Update on Its Generic Versions of Keppra XR(R) and Pristiq(R)
[at noodls] – TORONTO, March 13, 2013 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and … moreView todays social media effects on IPCIView the latest stocks trending across Twitter. Click to view dashboardSee who Intellipharmaceutics is hiring next, click here to view […]
INTELLIPHARMACEUTICS INTERNATIONAL INC. Financials
moreView todays social media effects on IPCIView the latest stocks trending across Twitter. Click to view dashboardSee who Intellipharmaceutics is hiring next, click here to view […]
Small Pharma Watch List: Week Of January 21st
moreView todays social media effects on IPCIView the latest stocks trending across Twitter. Click to view dashboardSee who Intellipharmaceutics is hiring next, click here to view […]
Intellipharmaceutics Closes US$1.5 Million Convertible Debenture Financing
[at noodls] – TORONTO, Jan. 10, 2013 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and … moreView todays social media effects on IPCIView the latest stocks trending across Twitter. Click to view dashboardSee who Intellipharmaceutics is hiring next, click here to view […]
